Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.75
Bid: 13.50
Ask: 14.00
Change: -0.25 (-1.79%)
Spread: 0.50 (3.704%)
Open: 14.00
High: 14.00
Low: 13.75
Prev. Close: 14.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Venture Company

17 May 2006 07:00

Angle PLC17 May 2006 For Immediate Release 17 May 2006 ANGLE plc ('ANGLE' or 'the Company') New Venture Company: Kaloptics, Inc. ANGLE plc ('ANGLE'), the venture management and consulting company specialising in the commercialisation of technology, is pleased to announce that it has signed an agreement with New York University (NYU) to commercialise innovative technology developed at the Media Research Lab in the Computer Science Department of NYU's Courant Institute of Mathematical Sciences. The agreement was effective on 30 April but for reasons of commercial confidentiality was embargoed until now. Researchers Ken Perlin, PhD and Jeff Han have developed a patent-pendingkaleidoscope and software system that enables the rapid capture and recreationof photo-realistic surface images. The technology has a wide range of commercialapplications in multi-billion dollar industries, including special effects,animation, computer gaming and medical devices. As part of its normal model for venture creation, ANGLE has formed and willincubate Kaloptics, Inc. to lead the technology commercialisation, market and IPassessment, and business strategy. ANGLE will contribute the initial managementof Kaloptics and lead a seed financing round for the company. Ken Perlin is a professor in the Department of Computer Science at NYU and wasfounding director of its Media Research Lab. His research interests includegraphics, animation, user interfaces and multimedia. He also received an AcademyAward for Technical Achievement from the Academy of Motion Picture Arts andSciences. Jeff Han, a computer science researcher at NYU, has been working in the fieldsof real-time computer graphics, computer vision, human-computer interfaces andmachine learning for over ten years. ANGLE's Chief Executive, Andrew Newland, said: "We are delighted to be working with New York University and its Media ResearchLab. These are world-class researchers who have produced numerous contributionsto their fields. We believe that the Kaleidoscope system can address a majorissue in multiple markets - the cost effective acquisition of data that can beused for the creation of realistic surface images." For further information ANGLE plc +44 1483 295830Andrew Newland, Chief ExecutiveRob Kornblum, Managing Director US Ventures Buchanan Communications +44 20 7466 5000Richard Darby, Suzanne Brocks, James Strong, Amy Rajendran Note to editors: About ANGLE Founded in 1994, ANGLE is an international venture management and consultingcompany focusing on the commercialisation of technology and the development oftechnology-based industry. ANGLE creates, develops and advises technologybusinesses on its own behalf and for its clients. ANGLE operates from offices inthe UK, the US and the Middle East. ANGLE is listed on AIM (AGL.L); further information can be found atwww.angleplc.com About NYU New York University, located in the heart of Greenwich Village, was establishedin 1831 and is one of America's leading research universities and a member ofthe selective Association of American Universities. It is one of the largestprivate universities, it is a leader in attracting international students andscholars in the U.S, and it sends more students to study abroad than any otherU.S. college or university. Through its 14 schools and colleges, NYU conductsresearch and provides education in the arts and sciences, law, medicine,business, dentistry, education, nursing, the cinematic and performing arts,music, public administration, social work, and continuing and professionalstudies, among other areas. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th Mar 20128:00 amRNSHolding(s) in the Company
28th Feb 201212:00 pmRNSDirector Share Transfer
28th Feb 20128:00 amRNSTotal Voting Rights
27th Feb 20127:00 amRNSParsortix Research Partnership
22nd Feb 20127:00 amRNSSecond Novocellus Patent
26th Jan 20127:00 amRNSInterim Results
26th Jan 20127:00 amRNSNovocellus Update
26th Jan 20127:00 amRNSFundraising
23rd Jan 20127:01 amRNSParsortix Update
19th Jan 20127:00 amRNSNotice of Interim Results and Webcast
16th Dec 20117:00 amRNSParsortix Update - Validation for Lung Cancer
7th Dec 20117:00 amRNSParsortix Update
21st Nov 20117:00 amRNSShare Options
16th Nov 20117:00 amRNSNovocellus Update
15th Nov 20117:00 amRNSIssue of equity and Total Voting Rights
11th Nov 20117:00 amRNSValidation for Prostate Cancer
10th Nov 20117:00 amRNSChange of Adviser
7th Nov 20113:53 pmRNSACOLYTE BIOMEDICA COURT JUDGEMENT
31st Oct 20117:00 amRNSWORLD TECHNOLOGY NETWORK AWARD
27th Oct 20119:26 amRNSDirector's share transfer
24th Oct 20117:00 amRNSPortfolio Company Announces Strengthening Sales
12th Oct 20117:00 amRNSIssue of equity and Total Voting Rights
6th Oct 20112:33 pmRNSResults of 2011 Annual General Meeting
6th Oct 20117:00 amRNS2011 AGM Statement
5th Oct 20117:00 amRNSParsortix Update and Issue of Equity
4th Oct 20117:00 amRNSWEB CAST - Parsortix Update
28th Sep 20117:00 amRNSParsortix Update
15th Sep 20113:20 pmRNSHolding(s) in Company
14th Sep 20119:16 amRNSAnnual Report and Accounts and Notice of AGM
13th Sep 20113:54 pmRNSHolding(s) in Company
12th Sep 20112:53 pmRNSHolding(s) in Company
8th Sep 20115:26 pmRNSHolding(s) in Company
31st Aug 20112:44 pmRNSShare Options
26th Aug 20114:26 pmRNSHolding in Company
17th Aug 20117:00 amRNSIssue of equity and Total Voting Rights
28th Jul 20117:00 amRNSPreliminary Results
25th Jul 20117:00 amRNSGeomerics Announces Agreement with Epic Games
15th Jul 20117:00 amRNSConditional Fundraising
28th Jun 20117:00 amRNSParsortix Update
18th May 20117:00 amRNSAcolyte Biomedica Update
5th May 20117:00 amRNSParsortix Update
28th Apr 20117:00 amRNSGeomerics Corporate Deal Further Progress
14th Apr 20117:00 amRNSGeomerics progress
2nd Mar 20114:54 pmRNSDirector/PDMR Shareholding
1st Mar 20117:00 amRNSGeomerics Real-Status deal
27th Jan 20117:00 amRNSInterim Results
25th Jan 20119:00 amRNSNotice of Interim Results
12th Jan 20117:00 amRNSGeometrics Corporate Deal Update
7th Jan 20117:00 amRNSNeuroTargets Patent Grant
6th Dec 201011:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.